Table 1.
Baseline patient characteristics.
| Characteristics | No TRT, N = 591 | TRT, N = 591 | p-value2 |
|---|---|---|---|
| Median age | 71 (65, 75) | 64 (60, 69) | <0.001 |
| Sex | |||
| Female | 22 (37%) | 26 (44%) | |
| Male | 37 (63%) | 33 (56%) | |
| Metastatic sites | |||
| Lung | 0.7 | ||
| No | 4 (6.8%) | 5 (8.5%) | |
| Yes | 55 (93%) | 54 (92%) | |
| Liver | 0.6 | ||
| No | 47 (80%) | 48 (81%) | |
| Yes | 12 (20%) | 11 (19%) | |
| Brain | >0.9 | ||
| No | 50 (85%) | 49 (83%) | |
| Yes | 9 (15%) | 10 (17%) | |
| Bone | 0.8 | ||
| No | 42 (71%) | 41 (69%) | |
| Yes | 17 (29%) | 18 (31%) | |
| Adrenal gland | 0.7 | ||
| No | 48 (81%) | 47 (80%) | |
| Yes | 11 (19%) | 12 (20%) | |
| Lymph nodes | 0.026 | ||
| No | 44 (75%) | 32 (54%) | |
| Yes | 15 (25%) | 27 (46%) | |
1n (%); Median (IQR);
2Pearson’s Chi-squared test; Fisher’s exact test.